首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Hematology-oncology clinics of north america

缩写:HEMATOL ONCOL CLIN N

ISSN:0889-8588

e-ISSN:1558-1977

IF/分区:2.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1386
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
David S Shulman,Brian D Crompton David S Shulman
We assess the emerging role of liquid biopsies, particularly circulating tumor DNA (ctDNA), in sarcoma management. Preliminary studies suggest that ctDNA has multiple potential applications including, early detection in patients with cancer...
Candace L Haddox,David J Papke Jr,César Serrano Candace L Haddox
Leiomyosarcomas (LMS) are mesenchymal malignancies with smooth muscle differentiation that most commonly arise in the uterus, retroperitoneum, and extremity. Clinical course is variable, and management differs by site of origin. Recently co...
Aaron R Weiss,Andrea Ferrari,Leo Mascarenhas et al. Aaron R Weiss et al.
Soft tissue sarcomas (STS) are rare mesenchymal tumors representing up to 7% of all cancers in children. In the pediatric population, rhabdomyosarcoma (RMS) is the most common histology while the remainder is composed of several distinct hi...
Maria Del Carmen Rodriguez Pena,David J Papke Jr Maria Del Carmen Rodriguez Pena
The increasingly widespread availability of next-generation sequencing has led to its incorporation as a diagnostic tool in pathology and a modality for identifying targetable alterations. However, sequencing is still a somewhat expensive a...
Elizabeth H Baldini,Alessandro Gronchi Elizabeth H Baldini
Soft tissue sarcoma is a rare heterogeneous group of tumors made up of over 100 histologic types and subtypes. Expert pathology review is crucial to confirm the correct diagnosis prior to treatment. Multidisciplinary discussion and manageme...
Michael W Bishop Michael W Bishop
Osteosarcoma is the most common primary bone malignancy of childhood and adolescence. Despite advances in cures for many pediatric neoplasms, outcomes for osteosarcoma have not significantly changed for nearly 4 decades and treatment is sim...
Sylvie Bonvalot,Aisha Miah,Bernd Kasper Sylvie Bonvalot
DT is a rare monoclonal fibroblastic neoplasm with an unpredictable biologic behavior. Over the past 15 y, the worldwide approach to desmoid tumor (DT) has shifted dramatically from surgery, when feasible, to frontline active surveillance i...
Alessandra Merlini,Angelo Paolo Dei Tos,Pan Pantziarka et al. Alessandra Merlini et al.
Ultra-rare sarcomas are sarcomas with an incidence of 1 case per million inhabitants per year, in which rarity poses a barrier to conducting histotype-specific randomized studies. This manuscript provides practical information and reference...
Carlo M Cicala,Sebastian Bauer,Michael C Heinrich et al. Carlo M Cicala et al.
This review discusses the current and future landscape of advanced gastrointestinal stromal tumor (GIST) treatment. It covers the role of tyrosine kinase inhibitors (TKIs), specifically imatinib, and further treatment options, such as sunit...
Sarah Nikiforow,Christine N Duncan Sarah Nikiforow
The main indication for allogeneic HSCT in children is primary/familial HLH but indications in adults are diverse, including malignancy-associated HLH. Matched related donors have historically been the preferred stem cell source (if not sha...